Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    Includes Expert Content
    Intermittent ADT
    avatar
    cagey8828 posted:
    I am a 68 year old who underwent laparoscopic nerve sparing surgery
    in Jan 2008. Initial PSA was 4.47 (while on oral finasteride). Pathology revealed positive margin at the bladder neck and minimal microscopic
    involvement of one seminal vesicle. Gleason score was 7 (4+3).
    One year later PSA increased and I underwent radiation therapy.
    In spite of this, PSA rose 10 months later. Doubling time of PSA appeared to be about 3 mo. 0.38, 0.78, 1.44. Combined androgen blockade was started. First PSA was 0.14 and all subsequent tests
    are below level of detection (?< 0.10). I am now at 15 months on CAB
    and am trying to decide the value/risks of attempting intermittent therapy with CAB. I feel fortunate to have experienced this response.

    I am aware of potential benefits but have trouble assessing whether
    there is a risk of earlier androgen independence. I would be interested
    in hearing professional opinion on this matter. I am aware that there are not prospective studies available to help answer this question..
    Reply
     
     
    avatar
    Basir U Tareen, MD responded:
    You are correct in that there are not any good prospective trials looking at intermittent androgen deprivation. There is a growing number of urologists, however, (including myself) who are starting to use intermittent ADT in light of increasing knowledge of the harmful effects of long term ADT.

    I don't believe there is any data to suggest that using intermittent ADT (ie, re-starting ADT when the PSA starts to rise or perhaps using an arbitrary cutoff such as PSA of 10 or doubling time <6 months) has a detrimental impact on overall survival.

    I have found that many of my patients appreciate the "drug holiday" and report significant improvement in quality of life when they are able to come off the hormonal therapy -- even if its for a short amount of time.
     
    avatar
    cagey8828 replied to Basir U Tareen, MD's response:
    Thank you both for your response. I am presently on my second round of suppressive therapy. I chose to start early and restart early with the feeling that development of adrogen resistence may well be related to total tumor mass and may be a random event/mutation. So far so good with rapid re-suppression after therapy. kg
     
    avatar
    cagey8828 replied to Anon_12340's response:
    Thanks, see below. kg


    Helpful Tips

    How to get the most out of your prostate cancer consultationExpert
    Here are a few tips to get the most out of your prostate cancer surgical or radiation oncology consultation: 1. Have extra copies of all ... More
    Was this Helpful?
    5 of 5 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    For more information, visit the Duke Health Prostate Cancer Center